Jean-Francois Fonteneau

ORCID iD
https://orcid.org/0000-0002-3284-8319
  • Country
  • Show details Hide details
France

Sources:
Jean-Francois Fonteneau (2016-01-24)

  • Keywords
  • Show details Hide details
Cancer, antitumor immune response, immunogenic cell death, oncolytic virus, measles virus,T lymphocytes, dendritic cells, tumor antigens

Sources:
Jean-Francois Fonteneau (2014-03-20)

  • Websites
  • Show details Hide details
Centre de Recherche en Cancérologie Nantes-Angers (CRCNA)

Sources:
Jean-Francois Fonteneau (2015-11-16)

INSERM UMR892 team4

Sources:
Jean-Francois Fonteneau (2015-11-16)

  • Other IDs
  • Show details Hide details
ResearcherID: L-4095-2015

Sources:
Clarivate Analytics (2015-11-16)

Biography

I received the Ph.D. degree from Nantes University, France, in 1999. During my thesis training (1995-1999), I studied CD8+ T lymphocytes response against melanoma in the INSERM Laboratory of Pr Francine Jotereau, Nantes, France. I then joined Dr Nina Bhardwaj’s group in Dr Ralph Steinman Laboratory as a Postdoctoral Fellow at Rockefeller University, New York, USA, from 1999 to 2003, where I studied dendritic cells (DC) biology, notably cross-presentation of viral and tumor antigens and interactions between virus/myeloid DC/plasmacytoid DC. In 2003, I returned to Pr Francine Jotereau Laboratory, INSERM U892, Nantes to identify new melanoma epitopes recognized by patient’s CD8+ and CD4+ T cells. In 2009, I joined Dr Marc Gregoire's Laboratory, INSERM U892, Nantes, to study attenuated measles virus as an oncolytic virus for antitumor virotherapy of pleural mesothelioma to induce immunogenic cell death of tumor cells.
  • : , ,

    {{group.getActive().startDate.year}}-{{group.getActive().startDate.month}}-{{group.getActive().startDate.day}} to present {{group.getActive().endDate.year}}-{{group.getActive().endDate.month}}-{{group.getActive().endDate.day}} {{group.getActive().endDate.year}}-{{group.getActive().endDate.month}}-{{group.getActive().endDate.day}} |  ()
    • Show Details Hide Details
    Organization identifiers
    {{group.getActive().orgDisambiguatedName}}: {{group.getActive().orgDisambiguatedCity}}, {{group.getActive().orgDisambiguatedRegion}}, {{group.getActive().orgDisambiguatedCountry}}
    Other organization identifiers provided by {{group.getActive().disambiguationSource.value}}
    • {{orgDisambiguatedExternalIdentifier.identifierType}}: {{orgDisambiguatedExternalIdentifier.preferred}} (preferred), {{orgDisambiguatedExternalIdentifierAll}}{{$last ? '' : ', '}}
    Created
    Source: {{(group.getActive().sourceName == null || group.getActive().sourceName == '') ? group.getActive().source : group.getActive().sourceName}}
No education added yet
  • : , ,

    {{group.getActive().startDate.year}}-{{group.getActive().startDate.month}}-{{group.getActive().startDate.day}} to present {{group.getActive().endDate.year}}-{{group.getActive().endDate.month}}-{{group.getActive().endDate.day}} {{group.getActive().endDate.year}}-{{group.getActive().endDate.month}}-{{group.getActive().endDate.day}} |  ()
    • Show Details Hide Details
    Organization identifiers
    {{group.getActive().orgDisambiguatedName}}: {{group.getActive().orgDisambiguatedCity}}, {{group.getActive().orgDisambiguatedRegion}}, {{group.getActive().orgDisambiguatedCountry}}
    Other organization identifiers provided by {{group.getActive().disambiguationSource.value}}
    • {{orgDisambiguatedExternalIdentifier.identifierType}}: {{orgDisambiguatedExternalIdentifier.preferred}} (preferred), {{orgDisambiguatedExternalIdentifierAll}}{{$last ? '' : ', '}}
    Created
    Source: {{(group.getActive().sourceName == null || group.getActive().sourceName == '') ? group.getActive().source : group.getActive().sourceName}}
No employment added yet
No publications added yet